Akums Drugs & Pharmaceuticals Ltd Share Price Today - Akums Drugs & Pharmaceuticals Ltd Stock Price Live NSE/BSE

Akums Drugs & Pharmaceuticals Ltd

NSE: AKUMS BSE: 544222

₹527.90

(-2.30%)

Tue, 19 May 2026, 11:27 am

MTF 5xInvest in Akums Drugs & Pharmaceuticals Ltd with 5x Leverage Buy with MTF

Market Cap85.14B

PE Ratio25.40

Dividend0

Health Technology

Biotechnology

24.5K

Akums Drugs & Pharmaceuticals Share Price Live Chart

1 Day

(-2.30%)

No Result Found

Summary

Market Cap
8186.06
Net Profit
343.78
P/B
2.38
Sector P/E
35.36
P/E
21.48
EV/EBITDA
12.71
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.05
RONW (Industry)
13.18
ROE
18.30
ROCE
12.86
Debt/Equity
0.17
EPS (TTM)
17.07
Dividend Yield
0.56
Book Value
210.57
Interest Cover
10.98

Analysis

No Result Found

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	75.26	75.26	75.26	75.26	75.26
FII	1.37	1.15	2.28	4.24	5.77
DII	14.35	14.40	9.28	8.85	7.40
Public	9.02	9.19	13.19	11.65	11.58
Government	0	0	0	0	0

Technical Analysis

RSI

46.78

MACD

3.11

50 DMA

510.90

200 DMA

470.29

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	692.27	609.17	578.23	526.07	495.13	442.97	359.87
Fibonacci	609.17	577.42	557.81	526.07	494.32	474.71	442.97
Camarilla	570.15	562.53	554.92	526.07	539.68	532.06	524.45

Pivots Level: Classic

+166.20

692.27

+83.10

609.17

+52.17

578.23

526.07

Pivot Point

LTP: 519.80

-30.93

495.13

-83.10

442.97

-166.20

359.87

Moving Average

SMAEMA

Period

Value

10-EMA
530.06
20-EMA
530.60
30-EMA
525.76
50-EMA
514.15
100-EMA
495.71
200-EMA
500.86

Announcement Date	Purpose	Action
14 May 2026	board-meetings	Accounts, Quarterly Results, Final Dividend
14 May 2026	agm
13 Feb 2026	board-meetings	Quarterly Results, Nine Months Results
13 Nov 2025	board-meetings	Quarterly Results
26 May 2025	agm

Akums Drugs & Pharmaceuticals Ltd

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Divis Laboratories Ltd

Cipla Ltd

Akums Drugs & Pharmaceuticals Ltd About

Akums Drugs & Pharmaceuticals is engaged in contract manufacturing which involves manufacturing of pharmaceutical formulations and specializes in developing new formulations, undertaking bio equivalence studies, clinical trials, obtaining Drug Controller General of India's (DCGI) approval for manufacturing and marketing new Fixed Dose Combinations (FDCs) & molecules and thereby offering new formulations with Company's own technology to its customers under their brand names.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2004

Headquarters

CEO

Employees

Contact

Website

http://www.akums.in

cs@akums.net

Phone

+91 11 6904 1000

Location

304 Mohan Place LSC Saraswati, Vihar, Delhi, Delhi, 110034

Year	History
2019	Ruby QC Investment Holdings Pte. Ltd. invested in the Company to become a minority shareholder
2021	Acquired Parabolic Drugs to form Akums Lifesciences Limited and ventured into APIs Akums Healthcare Limited acquired a facility at Kotdwar, Uttarakhand
2022	Acquired a facility in Haridwar, Uttarakhand through Akums Healthcare Limited Acquired a facility in Baddi, Himachal Pradesh through Pure and Cure Healthcare Private Limited Plants at 19, 20, 21, Sector 6A, SIDCUL, Haridwar, Uttarakhand and 2, 3, 4,5, Sector 6B, SIDCUL, Haridwar, Uttarakhand were accredited with European Union-Good Manufacturing Practices
2023	Acquired another facility in Baddi, Himachal Pradesh through Pure and Cure Healthcare Private Limited Merged Akums Lifesciences Limited with Pure and Cure Healthcare Private Limited
2024	The Company informed the exchange about new product launches.

Client Name	Deal Type	Order Side	QTY	Avg Price	Date
RUBY QC INVESTMENT HOLDINGS PTE.LTD.	block	Sell	7278535	428	22 Dec 2025
ICICI PRUDENTIAL MUTUAL FUND	bulk	Buy	7278535	428	22 Dec 2025
RUBY QC INVESTMENT HOLDINGS PTE.LTD.	bulk	Sell	7278535	428	22 Dec 2025
ICICI PRUDENTIAL MUTUAL FUND	block	Buy	7278535	428	22 Dec 2025
SMALLCAP WORLD FUND INC	bulk	Buy	2586541	753.84	06 Aug 2024

Akums Drugs & Pharmaceuticals Ltd News

Akums Drugs Q4 FY26: CDMO Drives 61.6% EBITDA Growth

Akums Drugs Q4 FY26 Adj EBITDA up 61.6% YoY to ₹152 crore; FY26 revenue ₹4,359 crore, +5.9% YoY. CDMO revenue ₹952 crore in Q4. Board declares ₹3/share dividend.

15 May 2026

companies

Akums Drugs Faces Ops Disruption at Haridwar Sites

Akums Drugs & Pharma reports temporary disruption at Haridwar manufacturing sites due to labour unrest at SIDCUL industrial area on May 14, 2026.

14 May 2026

companies

Akums Drugs FY26: PAT ₹2,564M, Q4 EBITDA Doubles, ₹3 Dividend

Akums Drugs FY26 consolidated PAT at ₹2,563.97M on total income of ₹44,877.42M. Q4 EBITDA rose to ₹1.5B vs ₹939M YoY. Board declares ₹3/share dividend; AGM on July 10, 2026.

14 May 2026

companies

Akums Drugs FY26 PAT ₹2,564M; Board Declares ₹3 Dividend

Akums Drugs FY26 consolidated PAT at ₹2,563.97M on total income of ₹44,877.42M. Q4 EBITDA rose to ₹1.5B vs ₹939M YoY. Board declares ₹3/share dividend; AGM on July 10, 2026.

14 May 2026

companies

Akums Drugs FY26: Q4 EBITDA Doubles, ₹3 Dividend Declared

Akums Drugs Q4 consolidated EBITDA rose to ₹1.5B vs ₹939M YoY; EBITDA margin expanded to 13.1%. FY26 consolidated PAT at ₹2,563.97M; ₹3/share dividend declared.

14 May 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800